The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Investigations on synthesis and structure elucidation of novel [1,2,4]triazolo[1,2-a]pyridazine-1-thiones and their inhibitory activity against inducible nitric oxide synthase.EBI
Ernst-Moritz-Arndt University Greifswald
New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714.EBI
Instituto Cajal (Csic)
Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).EBI
Neuraxon
Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors.EBI
Neuraxon
L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.EBI
G. D. Searle Research and Development
Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.EBI
Neuraxon
Success stories of natural product-based hybrid molecules for multi-factorial diseases.EBI
Punjabi University